MCP
BIOA

Militia Capital Partners’s BioAge Labs BIOA Stock Holding History

Militia Capital Partners’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$533K Hold
40,300
– – 0.2% 135
2025
Q3 		$237K Hold
40,300
– – 0.11% 155
2025
Q2 		$166K Buy
+40,300
New +$162K 0.08% 153

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return

Militia Capital Partners's BIOA Position: Q4 2025 in Review

Militia Capital Partners held its BioAge Labs (BIOA) position steady in Q4 2025 at 40,300 shares worth $533K. The position accounts for 0.2% of the portfolio, ranked #135.

Militia Capital Partners first reported a position in BIOA in Q2 2025 and has held it in 3 quarters since. 114 funds tracked by Wall St. Rank hold BIOA as of Q4 2025.

  • Militia Capital Partners held 40,300 shares of BioAge Labs worth $533K as of Q4 2025.
  • Militia Capital Partners left its BioAge Labs share count unchanged in Q4 2025.
  • BioAge Labs made up 0.2% of Militia Capital Partners's portfolio in Q4 2025, its #135 holding.
  • Militia Capital Partners first reported a position in BioAge Labs in Q2 2025 and has held it in 3 quarters since.
  • 114 funds tracked by Wall St. Rank held BioAge Labs as of Q4 2025.

Based on Militia Capital Partners's 13F filing for Q4 2025, filed 17 Feb 2026.